Response to Cough Controlled by Antitussives Does NOT Rule Out Asthma
A cough that responds to antitussive medications (like codeine or dextromethorphan) does NOT exclude asthma as the underlying diagnosis. In fact, asthma-related cough often requires specific anti-asthmatic therapy (inhaled corticosteroids and bronchodilators) for definitive resolution, and symptomatic improvement with antitussives merely masks the underlying airway inflammation without treating it 1.
Why Antitussive Response is Misleading
- Antitussives suppress the cough reflex centrally without addressing the underlying pathophysiology that triggers the cough 2, 3.
- Asthma causes cough through airway inflammation and bronchial hyperresponsiveness, mechanisms that antitussives do not treat 1.
- The diagnosis of cough-variant asthma (CVA) is only confirmed after resolution of cough with specific antiasthmatic therapy, not with symptomatic antitussive treatment 1.
The Correct Diagnostic Approach
Step 1: Systematic Evaluation for Asthma
- Medical history alone is unreliable for ruling in or ruling out asthma as a cause of chronic cough 1.
- Perform spirometry first to assess for reversible airflow obstruction 1.
- If spirometry is normal, bronchoprovocation challenge (BPC) with methacholine should be performed to detect bronchial hyperresponsiveness 1.
- A negative BPC has a negative predictive value close to 100%, effectively ruling out asthma 1.
- A positive BPC has a positive predictive value of 60-88%, warranting a trial of anti-asthmatic therapy 1.
Step 2: Therapeutic Trial for Asthma
- Initiate treatment with inhaled corticosteroids (ICS) plus inhaled β-agonists as first-line therapy for suspected asthmatic cough 1, 4.
- Expect at least partial improvement within 1 week, but complete resolution may require up to 8 weeks of treatment 1.
- If response is incomplete with ICS and bronchodilators, add a leukotriene receptor antagonist (such as montelukast) before escalating to oral corticosteroids 1.
- For severe or refractory cases, a short course of oral corticosteroids (prednisone 40 mg daily for 5-10 days) may be necessary to confirm the diagnosis 1.
Critical Pitfall to Avoid
Do not conclude that asthma is absent simply because antitussives provide symptomatic relief. This is a common error that delays appropriate diagnosis and treatment 1. Antitussives like codeine and dextromethorphan are non-specific suppressants that work on any cough, regardless of etiology 2, 3, 5.
When Asthma Treatment Should Be Pursued
- Asthma should always be considered as a potential etiology in any patient with chronic cough, even without wheezing or dyspnea 1.
- Cough-variant asthma presents with cough as the sole or predominant symptom, making clinical suspicion essential 1.
- Physical examination and spirometry may be entirely normal in CVA, necessitating BPC for diagnosis 1.
The Sequential Algorithm When Asthma is Suspected
- After treating upper airway cough syndrome (UACS) with first-generation antihistamine/decongestant combinations, evaluate for asthma next 1, 4.
- Perform BPC if available; if unavailable, proceed with empiric anti-asthmatic therapy 1.
- If asthma treatment fails after adequate trial (including oral corticosteroids), consider non-asthmatic eosinophilic bronchitis (NAEB) with induced sputum testing for eosinophils 1.
- If UACS, asthma, and NAEB have been adequately addressed without resolution, initiate empiric treatment for gastroesophageal reflux disease (GERD) 1, 4.
Key Distinction: Symptomatic vs. Definitive Treatment
- Antitussives provide symptomatic relief only and should be reserved for when definitive therapy cannot be given or when cough interferes with quality of life despite specific treatment 2, 3, 5.
- Definitive treatment depends on determining the underlying etiology and initiating specific therapy directed at that cause 2, 6.
- In asthma, definitive treatment is anti-inflammatory therapy with corticosteroids, not cough suppression 1.